Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 26, 2026
Why Is Tradr 2X Long AXTI Daily ETF (AXTX) ETF Up +5.33% Today?

Why Is Tradr 2X Long AXTI Daily ETF (AXTX) ETF Up +5.33% Today?

Key Takeaways

  • AXTX advanced 5.33% to $7.51, up from a prior close of $7.13.
  • The fund is a leveraged single-stock ETF targeting 2x the daily return of AXT, Inc. (AXTI), which climbed 3.13% to $67.45.
  • The primary catalyst was tightening indium phosphide (InP) substrate supply colliding with booming AI data-center optical demand.
  • Secondary drivers included fresh analyst upgrades and AXT's long-term supply agreements with major optical-component makers.
  • Record second-quarter results, a return to profitability, and a $100 million-plus backlog underpinned investor sentiment.
  • Investors are now watching export-permit dynamics, capacity expansion, and whether stretched valuations can hold.

Opening Summary

The AXTX ETF, formally the Tradr 2X Long AXTI Daily ETF, provides 2x daily leveraged exposure to AXT, Inc. (AXTI), a manufacturer of compound semiconductor substrates including indium phosphide (InP), gallium arsenide (GaAs), and germanium. In the latest completed session, AXTX rose 5.33%, closing at $7.51 versus a prior close of $7.13, as the underlying stock advanced 3.13% to $67.45. The move was driven by renewed optimism over AXT's position in a supply-constrained indium phosphide market feeding AI data-center connectivity.

Indium Phosphide Supply Tightening Meets AI Demand

The most immediate catalyst was reporting that indium phosphide substrate prices may rise further amid tightening supply. AXT is a leading supplier in a market where a global shortage is running into surging demand from AI data centers, which rely on InP-based lasers and optical transceivers for high-speed 800G and 1.6T connectivity. Because AXT controls a substantial share of global InP production, investors treated the scarcity as a direct positive for the company's pricing power and order flow.

Analyst Upgrades and a "Strong Buy" Catalyst

The rally was reinforced by a fresh round of bullish analyst commentary, including an upgrade to a top "Strong Buy" designation. Sell-side attention has centered on AXT's record InP revenue, its backlog exceeding $100 million with visibility into 2027, and aggressive capacity-expansion plans. The upgrades reframed the stock as a core "picks-and-shovels" play on the AI infrastructure buildout, drawing momentum-oriented and thematic capital back into the name.

Long-Term Supply Agreements Underpin the Rally

AXT's recent strategic agreements with key optical-component customers provided fundamental support. The company secured long-term supply and capacity-reservation arrangements with Lumentum (LITE), Coherent (COHR), and Casela, including sizable upfront deposits. These commitments validate multi-year demand, improve revenue visibility, and help fund AXT's plan to roughly double InP capacity again by 2027.

Which Holdings Contributed Most

Unlike diversified ETFs, AXTX does not hold a basket of stocks. It seeks 2x daily exposure to a single underlying security, AXT, Inc. (AXTI), using derivative instruments rather than direct share ownership. As a result, essentially all of the fund's daily performance is attributable to AXT's own price action, amplified by the 2x leverage target. When AXTI advanced roughly 3.13%, the leveraged structure translated that move into the larger percentage gain seen in AXTX, subject to fees, financing costs, and intraday rebalancing.

Market Context and Trading Activity

The advance marked a rebound from the prior session's risk-off pullback across AI-linked optical and hardware names. AXTX moved in line with its leveraged mandate, tracking the underlying stock's recovery rather than broad-market indices. The fund's elevated trading activity in recent sessions reflects strong speculative interest in the InP scarcity theme, though investors should note that leveraged single-stock ETFs are designed for short-term trading and can diverge from simple multiples of the underlying over holding periods longer than one day.

What Comes Next for AXTX

The near-term outlook hinges on several factors. Investors will watch whether indium phosphide pricing and shipments convert into continued revenue and margin gains, and whether AXT receives the export permits needed to recognize additional revenue from its China-based manufacturing. Capacity-execution milestones, progress on 6-inch InP substrates, and the trajectory of AI data-center capital spending are key watch items. Risks include AXT's significant China exposure, geopolitical and export-control uncertainty, customer concentration, and a valuation that already prices in substantial future growth. Any reversal in the underlying stock would be amplified to the downside by the fund's 2x leverage.

Trending AI Robots

Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, giving traders a way to monitor AI-driven signals across fast-moving names. Explore the page to see which automated strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AXTX

Contributor

My name is Jimmy, and I’m a financial analyst. I’m passionate about identifying the most promising ETFs for trading. Every day, I review hundreds of ETFs in search of trading and investment signals based on a variety of factors. I actively use technical analysis to identify short-term opportunities, including channels, indicators, support and resistance levels, and more. I also spend a great deal of time researching ETFs from a long-term investment perspective. My goal is to build a balanced ETF portfolio that combines investment-oriented and speculative ETFs and performs effectively during both market rallies and corrections.


Industry description

The investment seeks daily investment results, before fees and expenses, that correspond to two times (200%) the daily performance of the common shares of AXT, Inc. Under normal market circumstances, the fund will maintain at least 80% exposure to financial instruments that provide two times leveraged exposure to the daily performance of AXTI. It is non-diversified.
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Trading--Leveraged Equity
Address
Investment Managers Series Trust II803 West Michigan StreetMilwaukee
Phone
(414) 299-2295
Web
N/A
Interact to see
Advertisement
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Arm Holdings (ARM) shares have demonstrated resilience in recent sessions, rebounding after an initial earnings-related pullback and stabilizing near technical support levels. While smartphone-related headwinds tied to memory shortages pressured sentiment, momentum in AI-driven data center royalties helped restore confidence.
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
Copart (CPRT) is set to report fiscal Q2 2026 earnings on February 19, 2026, after market close. Consensus calls for EPS of $0.39–$0.40 and revenue of $1.15–$1.18 billion. Global Payments (GPN) posted Q4 2025 adjusted EPS of $3.18, in line with expectations, and adjusted net revenue of $2.32 billion, up 6% in constant currency (excluding dispositions). Thomson Reuters (TRI) delivered Q4 2025 adjusted EPS of $1.07 and revenue of $2.01 billion, up 5% year over year, supported by recurring subscription growth.
Unilever PLC (UL) leads year-to-date performance with a 12.61% gain, ahead of Diageo plc (DEO) at 9.90% and Keurig Dr Pepper Inc. (KDP) at 4.27%. DEO offers the highest dividend yield at 4.35%, compared with KDP (3.16%) and UL (2.97%). All three stocks carry low betas—DEO (0.18), UL (0.24), and KDP (0.35)—highlighting their defensive characteristics.
Q1 Fiscal 2026 Results: Revenue of $333M and adjusted EBITDA of $50M (15% margin), exceeding analyst expectations. FY2026 Guidance Raised: Adjusted EBITDA now projected at $225M, with revenue reaffirmed near $1.5B. EV Backlog Growth: 855 electric buses worth $277M, highlighting robust demand supported by EPA clean bus funding.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Why Is Tradr 2X Long AXTI Daily ETF (AXTX) ETF Up +5.33% Today?